Infectious Diseases

Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM. Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus[...]

By sjmartinez • January 8, 2025

Hernandez CJ, Sundar KG, Echegaray F, Cambou MC, Yang LZ, Segura ER, Gonçalves de Melo M, Santos BR, Varella IRDS, Nielsen-Saines K. The Benefits of[...]

By sjmartinez • January 8, 2025

Blair CS, Shoptaw SJ. Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication. Top Antivir Med. 2024 Dec 23;32(5):571-578. PMID: 39765236.

By sjmartinez • January 8, 2025

Galetti SC, Gadoth A, Halbrook M, Tobin NH, Ferbas KG, Rimoin AW, Aldrovandi GM. Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers[...]

By sjmartinez • January 4, 2025

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford[...]

By sjmartinez • January 3, 2025

Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe[...]

By sjmartinez • January 2, 2025

Walker D, Moucheraud C, Butler D, Takayama C, Shoptaw S, Currier JS, Gladstein J, Hoffman R. Telemedicine for HIV care: a cross-sectional survey of people[...]

By sjmartinez • January 2, 2025

Li Y, Mishra NN, Chen L, Manna AC, Cheung AL, Proctor RA, Xiong YQ. Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility[...]

By sjmartinez • January 2, 2025

Carnero Contentti E, Rojas JI, Alonso R, Yeaman MR, Weinshenker BG. Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine[...]

By sjmartinez • December 30, 2024

Mohammadi A, Chiang S, Li F, Wei F, Lau CS, Aziz M, Ibarrondo FJ, Fulcher JA, Yang OO, Chia D, Kim Y, Wong DTW. Direct[...]

By sjmartinez • December 29, 2024